ARTICLE | Clinical News
Zertane tramadol hydrochloride: Phase III start
March 18, 2013 7:00 AM UTC
Ampio said FDA accepted POPE as a co-primary endpoint for a U.S. Phase III trial of Zertane. The company said it is seeking to monetize the product through an acquisition or through licensing deals an...